CHD7 mutations causing CHARGE syndrome are predominantly of paternal origin

Clinical Genetics

Volumn 81, Issue 3, 2012, Pages 234-239

  Pauli, S ^a   von Velsen, N ^a   Burfeind, P ^a   Steckel, M ^a   Manz J ^a   Buchholz, A ^b   Borozdin, W ^b   Kohlhase, J ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CHARGE syndrome; CHD7; Parental origin; Paternal age

Indexed keywords

CHROMODOMAIN HELICASE DNA 7; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC LINKAGE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATERNAL AGE; PRIORITY JOURNAL; SYNDROME CHARGE;

ADULT; AGE FACTORS; CHARGE SYNDROME; COHORT STUDIES; DNA HELICASES; DNA-BINDING PROTEINS; FEMALE; GENETIC LINKAGE; GERM-LINE MUTATION; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC;

EID: 84856449269     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01701.x     Document Type: Article

References (40)

1. Hall BD. Choanal atresia and associated multiple anomalies. J Pediatr 1979: 95 (3): 395-398.
2. Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation - a syndrome. J Pediatr Ophthalmol Strabismus 1979: 16 (2): 122-128.
3. Pagon RA, Graham JM Jr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr 1981: 99 (2): 223-227.
4. Morgan D, Bailey M, Phelps P, Bellman S, Grace A, Wyse R. Ear-nose-throat abnormalities in the CHARGE association. Arch Otolaryngol Head Neck Surg 1993: 119 (1): 49-54.
5. Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet 2007: 15 (4): 389-399.
6. Vissers LE, van Ravenswaaij CM, Admiraal R et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004: 36 (9): 955-957.
7. Lalani SR, Safiullah AM, Fernbach SD et al. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet 2006: 78 (2): 303-314.
8. Jongmans MC, Admiraal RJ, van der Donk KP et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet 2006: 43 (4): 306-314.
9. Sanlaville D, Etchevers HC, Gonzales M et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet 2006: 43 (3): 211-217.
10. Vuorela P, Ala-Mello S, Saloranta C et al. Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions. Genet Med 2007: 9 (10): 690-694.
11. Wincent J, Holmberg E, Strömland K et al. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. Clin Genet 2008: 74 (1): 31-38.
12. Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS. Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A 1997: 94 (21): 11472-11477.
13. Flaus A, Martin DM, Barton GJ, Owen-Hughes T. Identification of multiple distinct Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res 2006: 34 (10): 2887-2905.
14. Flanagan JF, Blus BJ, Kim D, Clines KL, Rastinejad F, Khorasanizadeh S. Molecular implications of evolutionary differences in CHD double chromodomains. J Mol Biol 2007: 369 (2): 334-342.
15. Schnetz MP, Bartels CF, Shastri K et al. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 2009: 19 (4): 590-601.
16. Schnetz MP, Handoko L, Akhtar-Zaidi B et al. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet 2010: 6: e1001023.
17. Blake KD, Davenport SL, Hall BD et al. CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) 1998: 37 (3): 159-173.
18. Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD. An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet A 2005: 133A (3): 309-317.
19. Jongmans MC, Hoefsloot LH, van der Donk KP et al. Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am J Med Genet A 2008: 146A (1): 43-50.
20. Delahaye A, Sznajer Y, Lyonnet S et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet 2007: 72 (2): 112-121.
21. Pauli S, Pieper L, Häberle J et al. Proven germline mosaicism in a father of two children with CHARGE syndrome. Clin Genet 2009: 75 (5): 473-479.
22. Moloney DM, Slaney SF, Oldridge M et al. Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet 1996: 13 (1): 48-53.
23. Glaser RL, Jiang W, Boyadjiev SA et al. Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 2000: 66 (3): 768-777.
24. Wilkin DJ, Szabo JK, Cameron R et al. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 1998: 63 (3): 711-716.
25. Tartaglia M, Cordeddu V, Chang H et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet 2004: 75 (3): 492-497.
26. Böhm J, Munk-Schulenburg S, Felscher S, Kohlhase J. SALL1 mutations in sporadic Townes-Brocks syndrome are of predominantly paternal origin without obvious paternal age effect. Am J Med Genet A 2006: 140 (18): 1904-1908.
27. Trappe R, Laccone F, Cobilanschi J et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001: 68 (5): 1093-1101.
28. Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995: 4 (11): 2139-2143.
29. Splendore A, Jabs E, Felix T, Passos-Bueno MR. Parental origin of mutations in sporadic cases of Treacher-Collins syndrome. Eur J Hum Genet 2003: 11 (9): 718-722.
30. Tellier AL, Lyonnet S, Cormier-Daire V et al. Increased paternal age in CHARGE association. Clin Genet 1996: 50 (6): 548-550.
31. Rannan-Eliya SV, Taylor IB, De Heer IM, Van Den Ouweland AM, Wall SA, Wilkie AO. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. Hum Genet 2004: 115 (3): 200-207.
32. Schuffenecker I, Ginet N, Goldgar D et al. Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Am J Hum Genet 1997: 60 (1): 233-237.
33. Carlson KM, Bracamontes J, Jackson CE et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 1994: 55 (6): 1076-1082.
34. Penrose L. Parental age and mutation. Lancet 1955: 269 (6885): 312-313.
35. Driscoll DJ, Migeon BR. Sex difference in methylation of single-copy genes in human meiotic germ cells: implications for X chromosome inactivation, parental imprinting, and origin of CpG mutations. Somat Cell Mol Genet 1990: 16 (3): 267-282.
36. Glaser RL, Broman KW, Schulman RL, Eskenazi B, Wyrobek AJ, Jabs EW. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet 2003: 73 (4): 939-947.
37. Goriely A, McVean GA, Röjmyr M, Ingemarsson B, Wilkie AO. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003: 301 (5633): 643-646.
38. Crow JF. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 2000: 1 (1): 40-47.
39. + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol 2008: 153 (1): 75-80.
40. Felix TM, Hanshaw BC, Mueller R, Bitoun P, Murray JC. CHD7 gene and non-syndromic cleft lip and palate. Am J Med Genet A 2006: 140 (19): 2110-2114.